P16INK4a overexpression independent of Human Papilloma Virus (HPV) infection in rare subtypes of endometrial carcinomas

Pathology Research and Practice

Volumn 203, Issue 7, 2007, Pages 533-538

  Giordano, Giovanna ^a   Azzoni, Cinzia ^a   D'Adda, Tiziana ^a   Merisio, Carla ^b  

^a Laboratory Medicine   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Endometrial mucinous microglandular adenocarcinoma; Endometrial transitional cell carcinoma; P16INK4a expression; Primary squamous endometrial carcinoma

Indexed keywords

EOSIN; FORMALDEHYDE; HEMATOXYLIN; PARAFFIN; PROTEIN P16INK4A; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER CLASSIFICATION; CASE REPORT; DISEASE ASSOCIATION; ENDOMETRIUM CARCINOMA; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MUCINOUS CARCINOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; VERRUCA VULGARIS;

EID: 34447543991     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2007.03.001     Document Type: Article

References (35)

1. Ansari-Lari M.A., Staebler A., Zaino R.J., Shah K.V., and Ronnett B.M. Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection. Am. J. Surg. Pathol. 28 (2004) 160-167
2. Bergeron C., Shah K., Daniel R., and Ferenczy A. Search for human papillomaviruses in normal, hyperplastic, and neoplastic endometria. Obstet. Gynecol. 72 3 Part 1 (1988) 383-387
3. Czerwenka K., Lu Y., Heuss F., Manavi M., and Kubista E. Human papillomavirus detection of endometrioid carcinoma with squamous differentiation of the uterine corpus. Gynecol. Oncol. 61 (1996) 210-214
4. Fluhmann C.F. Squamous epithelium in the endometrium in benign and malignant conditions. Surg. Gynecol. Obstet. 46 (1928) 309-316
5. Fujita M., Shroyer K.R., Markham N.E., Inoue M., Iwamoto S., Kyo S., and Enomoto T. Association of human papillomavirus with malignant and premalignant lesions of the uterine endometrium. Hum. Pathol. 26 (1995) 650-658
6. Giordano G., D'Adda T., Merisio C., and Gnetti L. Primary squamous cell carcinoma of the endometrium: a case report with immunohistochemical and molecular study. Gynecol. Oncol. 96 (2005) 876-879
7. Giordano G., D'Adda T., Gnetti L., Merisio C., and Melpignano M. Endometrial mucinous microglandular adenocarcinoma: morphologic, immunohistochemical features, and emphasis in the human papillomavirus status. Int. J. Gynecol. Pathol. 25 (2006) 77-82
8. G. Giordano, T. D'Adda, L. Gnetti, C. Merisio, S. Raboni, Transitional cell carcinoma of the endometrium associated with benign ovarian Brenner tumor. A case report with immunohistochemical, molecular study and a review of the literature, Int. J. Gynecol. Pathol., in press.
9. Hording U., Daugaard S., and Visfeldt J. Adenocarcinoma of the cervix and adenocarcinoma of the endometrium: distinction with PCR-mediated detection of HPV DNA. APMIS 105 (1997) 313-316
10. Horn L.C., Richter C.E., Einenkel J., Tannapfel A., Liebert U.G., and Leo C. p16, p14, p53, cyclin D1, and steroid hormone receptor expression and human papillomaviruses analysis in primary squamous cell carcinoma of the endometrium. Ann. Diagn. Pathol. 10 (2006) 193-196
11. Im D.D., Shah K.V., and Rosenshein N.B. Report of three new cases of squamous carcinoma of the endometrium with emphasis in the HPV status. Gynecol. Oncol. 56 (1995) 464-469
12. Kataoka A., Nishida T., Sugiyama T., Hori K., Honda S., and Yakushiji M. Squamous cell carcinoma of the endometrium with human papillomavirus type 31 and without tumor suppressor gene p53 mutation. Gynecol. Oncol. 65 (1997) 180-184
13. Keating J.T., Cviko A., Reithdorf S., Riethdorf L., Quade B.J., Sun D., Duensing S., Sheets E.E., Munger K., and Crum C.P. Ki-67, cyclin E and p16 (INK4) are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am. J. Surg. Pathol. 25 (2001) 891-894
14. Klaes R., Friedrich T., Spitkovsky D., Ridder R., Rudy W., Petry U., Dallenbach-Hellweg G., Schmidt D., and von Knebel Doeberitz M. Overexpression of p16 (INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int. J. Cancer 92 (2001) 276-284
15. Klaes R., Benner A., Friedrich T., Ridder R., Herrington S., Jenkins D., Kurman R.J., Schmidt D., Stoler M., and von Knebel Doeberitz M. p16 ink4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am. J. Surg. Pathol. 27 (2003) 1284
16. Labontè S., Tetu B., Boucher D., and Larue H. Transitional cell carcinoma of the endometrium associated with a benign ovarian Brenner tumor: a case report. Hum. Pathol. 32 (2001) 230-232
17. Li Y., Nichols M.A., Shay J.W., and Xiong Y. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res. 54 (1994) 6078-6082
18. Lininger R.A., Wistuba I., Gazdar A., Koenig C., Tavassoli F.A., and Albores-Saavedra J. Human papillomavirus type 16 is detected in transitional cell carcinomas and squamotransitional cell carcinomas of the cervix and endometrium. Cancer 83 (1998) 521-527
19. McCluggage W.G., and Jenkins D. p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma. Int. J. Gynecol. Pathol. 22 (2003) 231-235
20. Melgoza F., Brewster W.R., Wilczynski S., and Rutgers J. p16-Positive small cell neuroendocrine carcinoma of the endometrium. Int. J. Gynecol. Pathol. 25 (2006) 252-256
21. Milde-Langosch K., Riethdorf L., Bamberger A.M., and Loning T. p16/MTS1 and pRB expression in endometrial carcinomas. Virchows Arch. 434 (1999) 23-28
22. Milde-Langosch K., Bamberger A.M., Goemann C., Rossing E., Rieck G., Kelp B., and Loning T. Expression of cell-cycle regulatory proteins in endometrial carcinomas: correlations with hormone receptor status and clinicopathologic parameters. J. Cancer Res. Clin. Oncol. 127 (2001) 537-544
23. Murphy N., Bermingham N., and Ring M. Immunocytochemical analysis of p16 protein in cervical cancer and cervical intraepithelial neoplasia. J. Pathol. 195 (2001) 2A
24. Nakashima R., Fujita M., Enomoto T., Haba T., Yoshino K., Wada H., Kurachi H., Sasaki M., Wakasa K., Inoue M., Buzard G., and Murata Y. Alteration of p16 and p15 genes in human uterine tumours. Br. J. Cancer 80 (1999) 458-467
25. Negri G., Egarter-Vigl E., Kasal A., Romano F., Haitel A., and Mian C. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am. J. Surg. Pathol. 27 (2003) 187-193
26. Paulsen H., and Taylor C. International Histological Classification of Tumors Histological Typing of Female Genital Tract Tumors, No. 13 (1975), World Health Organization
27. Salvesen H.B., Das S., and Akslen L.A. Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis. Clin. Cancer Res. 6 (2000) 153-159
28. Sano T., Oyama T., Kashiwabara K., Fukuda T., and Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am. J. Pathol. 153 (1998) 1741-1748
29. Semczuk A., Stenzel A., Baranowski W., Rozynska K., Cybulski M., Kostuch M., Jakowicki J., and Wojcierowski J. Detection of human papillomavirus types 16 and 18 in human neoplastic endometrium: lack of correlation with established prognostic factors. Oncol. Rep. 7 (2000) 905-910
30. Serrano M., Hannon G.J., and Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366 (1993) 704-707
31. Shiozawa T., Nikaido T., Shimizu M., Zhai Y., and Fujii S. Immunohistochemical analysis of the expression of cdk4 and p16INK4 in human endometrioid-type endometrial carcinoma. Cancer 80 (1997) 2250-2256
32. Tringler B., Gup C.J., Singh M., et al. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. Hum. Pathol. 35 (2004) 689-696
33. Tsuda H., Yamamoto K., Inoue T., Uchiyama I., and Umesaki N. The role of p16-cyclin d/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma. Br. J. Cancer 82 (2000) 675-682
34. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell 81 (1995) 323-330
35. Zidi Y.S., Bouraoui S., Atallah K., Kchir N., and Haouet S. Primary in situ squamous cell carcinoma of the endometrium, with extensive squamous metaplasia and dysplasia. Gynecol. Oncol. 88 (2003) 444-446